Horse source tetanus antibody

A tetanus and tetanus toxoid technology, applied in the field of immunology, can solve the problems of horse liver cell degeneration and necrosis, horse toxicity, and difficulty in producing highly specific antibodies, and achieve high purity and simple production

Inactive Publication Date: 2018-08-21
高台县天鸿生化科技开发有限责任公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are still some problems in the preparation of TAT: (1) During tetanus booster immunization in horses, it is difficult to produce highly specific antibodies due to the complex composition of tetanus toxoid; (2) Toxoid still has certain toxicity, often high After a dose of tetanus toxoid antigen injection, the blood collection will gradually cause degeneration and necrosis of the liver cells of the horse. Generally, the immune blood collection begins after the tenth stage of the horse, and the liver enlarges and degenerates, turning into a "tofu dregs" shape, and finally the edge of the liver ruptures. , resulting in the death of the horse
Although its immune effect is better, there are still some problems: (1) Clostridium tetani can form spores, which is highly toxic and has certain dangers during production; It is easy to cause side effects; (3) Toxoids after chemical treatment may also undergo toxicity reversal, causing toxicity to horses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Horse source tetanus antibody
  • Horse source tetanus antibody
  • Horse source tetanus antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038] In order to make the purpose, technical solutions and advantages of the present invention clearer, the technical solutions of the present invention will be described in detail below. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other implementations obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
weightaaaaaaaaaa
weightaaaaaaaaaa
Login to view more

Abstract

The invention relates to a horse source tetanus antibody. Horses which are free of natural antibodies and at appropriate ages, weights and good health states are selected, the horses are immunized with different dosages of tetanus sub-toxin fragments or mixed antigen of tetanus toxins, and then the antibody can be generated. The antibody has the beneficial effects that due to high immunogenicity of tetanus sub-toxins, the horse source tetanus antibody can be generated, can be massively produced without limits, is easy in quality control and is completely free of toxicity; and the antibody provided by the invention has an effect equivalent to that of a horse source tetanus antibody generated from tetanus toxin immunization.

Description

technical field [0001] The invention belongs to the technical field of immunology, and in particular relates to the use of tetanus subtoxin to immunize horses to produce equine tetanus antibodies. Background technique [0002] Tetanus is a serious infectious disease with a mortality rate as high as 20%-40%. Any trauma has the potential to develop tetanus. Tetanus antibody is the rapid and effective medicine of short-term prevention and treatment tetanus, and the tetanus treatment drug on the market at present has tetanus equine antitoxin (TAT) and tetanus human immunoglobulin (TIG). TIG is a specific immunoglobulin preparation extracted from plasma with high titer of tetanus antibody collected from blood donors immunized with tetanus toxoid after immunization with hepatitis B vaccine. TIG does not require a skin test and can be injected directly. However, because it is a blood product, there is a potential risk of infection with infectious diseases such as hepatitis C and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/12C07K16/06
CPCC07K16/06C07K16/1282
Inventor 沈光夫季冲敬玥
Owner 高台县天鸿生化科技开发有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products